A microfluidic device for label-free, physical capture of circulating tumor cell clusters
A. Fatih Sarioglu(Georgia Institute of Technology), Mehmet Toner(Shriners Hospitals for Children - Erie), David T. Ting(Massachusetts General Hospital), Ravi Kapur(Harvard University), Aditya Bardia(UCLA Health), Amanda Engstrom(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Maria Donaldson Collier(The Netherlands Cancer Institute), Mahnaz Zeinali(Massachusetts General Hospital), Nikola Kojić(Boston University), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Nicola Aceto(University of Basel), Bashar Hamza(Harvard University), Xi Luo(Harvard University), Huili Zhu(Yantai University), Tilak Sundaresan(Kaiser Permanente San Francisco Medical Center), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), David T. Miyamoto(Broad Institute)
Cited by 726
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k